Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-13
2010-11-09
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S265000
Reexamination Certificate
active
07829584
ABSTRACT:
The present invention describes compounds of Formula I:wherein W, X, Y, Z, and Q are defined herein, or a pharmaceutically acceptable salt thereof, for the prophylaxis, or treatment of diseases and conditions related to thrombin activity in a mammal.
REFERENCES:
patent: 4652440 (1987-03-01), Paik et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4957939 (1990-09-01), Gries et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5122361 (1992-06-01), Kung et al.
patent: 2003/0158218 (2003-08-01), Nantermet et al.
patent: 2164684 (1994-12-01), None
patent: 759429 (1997-02-01), None
patent: 761241 (1997-03-01), None
patent: 604022 (2007-06-01), None
patent: WO96/11668 (1996-04-01), None
patent: WO96/32143 (1996-10-01), None
patent: WO96/38136 (1996-12-01), None
patent: WO2004/091613 (2004-10-01), None
Naterme, P.G. et al., “P2 pyridine N-oxide thrombin inhibitors a novel peptidomimetic scaffold”, Bioorganic & Medicinal Chemistry Letters, vol. 15, Apr. 2005, pp. 2771-2775.
Angewandte Chemie92:390-391, 1980.
Biochem Pharmacol22: 3099-3108, Cheng Y and Prusoff WH (1973).
Bioorg. Med Chem. Lett.15:2771, 2005.
Bioorg. Med. Chem.10:1115-1122, 2002.
Bioorg. Med. Chem.6:1631-1639, '1998.
Can. J. Physiol. Pharmacol.77:79-88, 1999.
Chem. Pharm. Bull.48:982-990, 2000.
Chem. Soc. Rev.3:513-544, 1974.
Chemico-Biological Interactions117:191-217, 1999.
Collect. Czech. Chem. Commun.45:504-516, 1980.
Collect. Czech. Chem. Commun.64:649-672, 1999.
Helv. Chim. Acta59:229-235, 1976.
Helv. Chim. Acta77:1057-1064, 1994.
Heterocycles36:431-434, 1993), VII-3.
J. Am. Chem. Soc.105:7435-7442, 1983.
J. Am. Chem. Soc.118:2521-2522, 1996.
J. Am. Chem. Soc.122:712-713, 2000.
J. Am. Chem. Soc.125:12110-12111, 2003.
J. Antibiotics53:1086-1095, 2000.
Biol. Chem.121:235-253, 1937.
J. Biol. Chem.280:19496-19506, 2005.
J. Chem. Soc. C: Organic1375-1380, 1970), VII-4.
J. Fluorine Chem.18:497-506, 1981.
J. Heterocycl. Chem.34:145-151, 1997.
J. Heterocycl. Chem.38:1297-1306, 2001.
J. Labelled. Compd. Radiopharm.45:423-434, 2002.
J. Med. Chem.39:892-903, 1996.
J. Med. Chem.43:1754-1764, 2000.
J. Med. Chem.45:2841-2849, 2002.
J. Med. Chem.45:3639-3648, 2002.
J. Med. Chem.45:4755-4761, 2002.
J. Med. Chem.46:461-473, 2003.
J. Med. Chem.47:612-626, 2004.
J. Org. Chem.20:6781-6789, 2004.
J. Org. Chem.22:7752-7754, 2004.
J. Org. Chem.51:1889-1891, 1986.
J. Org. Chem.55:541-548, 1990.
J. Org. Chem.58:4642-4645, 1993.
J. Org. Chem.60:1408-1412, 1995.
J. Org. Chem.65:1158-1174, 2000.
J. Org. Chem.67:6550-6552, 2002.
J. Org. Chem.67:674-683, 2002.
J. Org. Chem.68:8838-8846, 2003.
J. Pharm. Sci.62:1900-1902, 1973.
J. Pharmaceutical Sci.64:367-391, 1975.
Journal of Heterocyclic Chemistry, 21:673-679, 1984.
Khaw et al.,Science209:295-297, (1980).
Labelled Compd. Radiopharm.36:685-699, 1995.
Life Sciences8:1123-1128, 1969.
Med. Chem.45:461-473, 2003.
Org. Lett.2:3425-3427, 2000.
Org. Process Res. Dev.8:192, 2004.
Organic Process Research&Development8:192-200, 2004.
Tetrahedron57:5321-5326, 2001.
Tetrahedron Lett.39:5159-5162, 1998.
Tetrahedron Lett.40:2481-2484, 1999.
Tetrahedron Lett.46:135-137, 2005.
United States Pharmacopeia/National Formulary for 1995, pp. 1636-1637, published by United States Pharmacopeial Convention, Inc., Rockville, Maryland (1994).
Chem. Pharm. Bull.47:1013, 1999.
Hu Huaping
Kreutter Kevin
Lu Tianbao
Player Mark R.
Teleha Christopher
Davis Zinna N
Dodd Thomas J.
Janssen Pharmaceutica NV
LandOfFree
Pyridines and pyridine N-oxides as modulators of thrombin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridines and pyridine N-oxides as modulators of thrombin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridines and pyridine N-oxides as modulators of thrombin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4206166